Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min-Hee Yi

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Scientific Reports|October 13, 2016
CD200R/Foxp3-mediated signalling regulates microglial activationMin-Hee Yi, Enji Zhang, Jwa-Jin Kim, et al.
Scientific Reports|April 7, 2020
Author Correction: CD200R/Foxp3-mediated signalling regulates microglial activationMin-Hee Yi, Enji Zhang, Jwa-Jin Kim, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2026
KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastomaEun-Jung Ahn, Sung Sun Kim, Sm Abdus Salam, et al.
Experimental Hematology & Oncology|October 1, 2025
Brain metastasis-associated cancer fibroblasts drive tumor progression and therapeutic resistance through IL26 and CX3CL1 signaling in non-small-cell lung cancerS M Abdus Salam, Eshrat Jahan, Eun-Jung Ahn, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Scientific Reports|October 13, 2016
CD200R/Foxp3-mediated signalling regulates microglial activationMin-Hee Yi, Enji Zhang, Jwa-Jin Kim, et al.
Scientific Reports|April 7, 2020
Author Correction: CD200R/Foxp3-mediated signalling regulates microglial activationMin-Hee Yi, Enji Zhang, Jwa-Jin Kim, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2026
KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastomaEun-Jung Ahn, Sung Sun Kim, Sm Abdus Salam, et al.
Experimental Hematology & Oncology|October 1, 2025
Brain metastasis-associated cancer fibroblasts drive tumor progression and therapeutic resistance through IL26 and CX3CL1 signaling in non-small-cell lung cancerS M Abdus Salam, Eshrat Jahan, Eun-Jung Ahn, et al.
Pageof 5